Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome

References

• Bouzas IC, Cader SA, Leão L, et al. Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27(6):1–5.
   PubMed Web of Science ®Google Scholar
• Ruan X, Li M, Mueck AO. Why does polycystic ovary syndrome (PCOS) need long-term management? Curr Pharm Des. 2018;24(39):4685–4692.
   PubMed Web of Science ®Google Scholar
• Bhattacharya SM, Jha A. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 ‘joint interim criteria’. J Obstet Gynaecol Res. 2011;37(10):1303–1307.
   PubMed Web of Science ®Google Scholar
• Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021;11(12):869.
   PubMed Web of Science ®Google Scholar
• Kumari B, Yadav UCS. Adipokine visfatin’s role in pathogenesis of diabesity and related metabolic derangements. Curr Mol Med. 2018;18(2):116–125.
   PubMed Web of Science ®Google Scholar
• Radzicka S, Pietryga M, Iciek R, et al. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol Pol. 2018;89(9):518–521.
   PubMed Web of Science ®Google Scholar
• Zhu S, Sun F, Li W, et al. Apelin stimulates glucose uptake through the PI3K/akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem. 2011;353(1–2):305–313.
   PubMed Web of Science ®Google Scholar
• Endocrinology Group and Guidelines Expert Group of the Chinese Medical Association Obstetrics and Gynecology Branch. Guidelines for diagnosis and treatment of polycystic ovary syndrome in China. Chin J Obstet Gynecol. 2018;53:2–6.
   Google Scholar
• Yin J, Li M, Xu L, et al. Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5(1):71.
   PubMed Web of Science ®Google Scholar
• Garruti G, de Palo R, Rotelli MT, et al. Association between follicular fluid leptin and serum insulin levels in non-overweight women with polycystic ovary syndrome. Biomed Res Int. 2014;2014:980429.
   PubMed Web of Science ®Google Scholar
• Gen R, Akbay E, Muslu N, et al. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance. Gynecol Endocrinol. 2009;25(4):241–245.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wu Z, Wei L, et al. High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis. Gynecol Endocrinol. 2015;31(10):808–814.
   PubMed Web of Science ®Google Scholar
• Farshchian F, Ramezani Tehrani F, Amirrasouli H, et al. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome. Int J Endocrinol Metab. 2014;12(3):e15503.
   PubMedGoogle Scholar
• Kamińska A, Kopczyńska E, Bronisz A, et al. An evaluation of visfatin levels in obese subjects. Endokrynol Pol. 2010;61(2):169–173.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Choi YM, Hong MA, et al. Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls. Obstet Gynecol Sci. 2018;61(2):253–260.
   PubMedGoogle Scholar
• Cekmez F, Cekmez Y, Pirgon O, et al. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. Eur Cytokine Netw. 2011;22(1):32–37.
   PubMed Web of Science ®Google Scholar
• Gümüş Ü, Güzel AI, Topcu HO, et al. Plasma visfatin levels in adolescents with polycystic ovary syndrome: a prospective case-control study. J Pediatr Adolesc Gynecol. 2015;28(4):249–253.
   PubMed Web of Science ®Google Scholar
• Asadi S, Goodarzi MT, Saidijam M, et al. Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes. Iran J Basic Med Sci. 2015;18(6):537–543.
   PubMed Web of Science ®Google Scholar
• Wang P, van Greevenbroek MM, Bouwman FG, et al. The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Arch. 2007;454(6):971–976.
   PubMed Web of Science ®Google Scholar
• Smith J, Al-Amri M, Sniderman A, et al. Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1. Clin Endocrinol (Oxf). 2006;65(5):667–672.
   PubMed Web of Science ®Google Scholar
• Martínez Larrad MT, Corbatón Anchuelo A, Fernández Pérez CM; Segovia Insulin Resistance Study Group (SIRSG), et al. Obesity and cardiovascular risk: variations in visfatin gene can modify the obesity associated cardiovascular risk. Results from the segovia population Based-Study. Spain. PLoS One. 2016;11(5):e0153976.
   PubMed Web of Science ®Google Scholar
• Gören K, Sağsöz N, Noyan V, et al. Plasma apelin levels in patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2012;13(1):27–31.
   PubMedGoogle Scholar
• Hasan MM, Abd El Hameed AA. Serum adipokine (apelin) in lean and obese polycystic ovary syndrome patients before and after metformin treatment. Middle East Fertility Society Journal. 2018;23(4):315–318.
   Web of Science ®Google Scholar
• Chang CY, Tsai YC, Lee CH, et al. Lower serum apelin levels in women with polycystic ovary syndrome. Fertil Steril. 2011;95(8):2520–2523.e1-2.
   PubMed Web of Science ®Google Scholar
• Altinkaya SÖ, Nergiz S, Küçük M, et al. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;176:168–172.
   PubMed Web of Science ®Google Scholar
• Benk Silfeler D, Gokce C, Keskin Kurt R, et al. Does polycystic ovary syndrome itself have additional effect on apelin levels? Obstet Gynecol Int. 2014;2014:536896.
   PubMedGoogle Scholar
• Olszanecka-Glinianowicz M, Madej P, Nylec M, et al. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clin Endocrinol (Oxf). 2013;79(2):238–242.
   PubMed Web of Science ®Google Scholar
• Kolahdouzi S, Baghadam M, Kani-Golzar FA, et al. Progressive circuit resistance training improves inflammatory biomarkers and insulin resistance in obese men. Physiol Behav. 2019;205:15–21.
   PubMed Web of Science ®Google Scholar
• Zheng XD, Huang Y, Li H. Regulatory role of apelin-13-mediated PI3K/AKT signaling pathway in the glucose and lipid metabolism of mouse with gestational diabetes mellitus. Immunobiology. 2021;226(5):152135.
   PubMed Web of Science ®Google Scholar